Research never stops

Top Story

Evotec achieves first milestone in Diabetes alliance with Sanofi

Hamburg, Germany 05 April 2017: Evotec AG today announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached an important milestone, triggering a payment of EUR 3.0 m to Evotec, for achieving pre-clinical proof-of-concept.

- read more

Evotec´s partner Forge Therapeutics receives prestigious Carb-X research award

Hamburg, Germany - 31 March 2017: Evotec AG today announced that its partner Forge Therapeutics has received a research award from CARB-X of $ 8.8 m to advance its novel Gram-negative antibiotic programme targeting LpxC for the treatment of bacterial infections.

- read more

Evotec fiscal year results 2016: Leading innovation efficiency & First-in-class drug discovery

Hamburg, Germany, 28 March 2017: Evotec AG today announced its financial results and corporate updates for the fiscal year ended 31 December 2016.

- read more
loading weather report
Loading weather report...


May 10, 2017 - New York Bio 2017 annual conference

May 22, 2017 - Bio€quity Europe 2017

Company Presentation April

Building integrated and high-value drug discovery alliances
2017-04_Evotec_Company presentation_April